Continued evolution of SARS-CoV-2 has led to the emergence of several new Omicron
subvariants, including BQ. 1, BQ. 1.1, BA. 4.6, BF. 7 and BA. 2.75. 2. Here we examine the …

… antibody-bound SARS-CoV-2 spike or RBD structures published in the RCSB Protein Data
Bank (PDB) (Fig. 1c–k). Although every antibody … 1.1.529 for antibody neutralization, we used …

… the SARS-CoV spike protein to isolate a neutralizing antibody from … N-linked glycan acquisition
by the SARS-CoV-2 RBD confers … of escape variants as SARS-CoV-2 adapts to humans. …

… of different replication sites could allow a better understanding of SARS-CoV-2 population
genetics and enable prediction of escape variants following antibody based therapies. …

… to escape the antibody response produced by vaccines or severe acute respiratory syndrome
coronavirus 2 (SARS-CoV… We describe a panel of 25 potent monoclonal antibodies (mAbs) …

… of anti-RBD antibodies with high-resolution structures. We compare the antibody-escape maps
to … plasma from individuals from whom some of the antibodies were isolated. The plasma-…

… potential for immune escape. Here, … escape from monoclonal antibody neutralization largely
driven by E484K, although K417N and N501Y act together against some important antibody …

… SARS-CoV-2 neutralizing antibodies we isolated from a healthy COVID-19 convalescent
donor. Resistance extends to the polyclonal serum immunoglobulins of four out of four healthy …

… antibodies with activity against emergent variants. To determine how SARS-CoV-2 might
escape these antibodies, … selection by 40 broadly neutralizing antibodies. We identify numerous …

… to monoclonal antibodies, to SARS-CoV-2 … for SARS-CoV-2-susceptible human cell lines;
however, the 501Y.V2 variants were less susceptible to the neutralizing activity of antibodies …